ACADIA Pharmaceuticals In... (ACAD)
NASDAQ: ACAD
· Real-Time Price · USD
25.30
0.77 (3.14%)
At close: Aug 15, 2025, 3:59 PM
25.33
0.12%
After-hours: Aug 15, 2025, 05:36 PM EDT
ACADIA Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 264.57M | 244.32M | 259.6M | 250.4M | 241.96M | 205.83M | 231.04M | 211.7M | 165.24M | 118.46M | 136.49M | 130.71M | 134.56M | 115.47M | 130.76M | 131.61M | 115.22M | 106.55M |
Cost of Revenue | 20.73M | 20.39M | 21.8M | 18.86M | 18.23M | 22.95M | 17.89M | 14.62M | 7.46M | 1.67M | 2.41M | 2.14M | 2.67M | 2.95M | 2.56M | 6.68M | 5.21M | 4.69M |
Gross Profit | 243.83M | 223.93M | 237.8M | 231.54M | 223.73M | 182.88M | 213.15M | 197.08M | 157.78M | 116.8M | 134.08M | 128.58M | 131.9M | 112.52M | 128.2M | 124.93M | 110.02M | 101.86M |
Operating Income | 32.37M | 19.29M | 153.5M | 31.64M | 30.44M | 15.21M | 34.94M | -57.78M | 3.04M | -53.58M | -46.06M | -30.87M | -33.65M | -113.02M | -44.66M | -15.3M | -43.71M | -66.77M |
Interest Income | 7.24M | n/a | 7.01M | 6.59M | 6.36M | 5.51M | 4.76M | 4.13M | 4.55M | 3.8M | 3.63M | 2.29M | 580K | 105K | 129K | 129K | 133K | 200K |
Pretax Income | 40.21M | 27.78M | 161.09M | 38.81M | 37.18M | 21M | 39.7M | -52.14M | 6.34M | -44.94M | -40.89M | -26.41M | -33.57M | -112.57M | -42.91M | -14.79M | -43.4M | -66.43M |
Net Income | 26.67M | 18.99M | 143.74M | 32.77M | 33.39M | 16.55M | 45.8M | -65.18M | 1.11M | -43.02M | -41.73M | -27.18M | -34.01M | -113.06M | -43.09M | -14.46M | -43.87M | -66.45M |
Selling & General & Admin | 133.51M | 126.37M | 130.08M | 133.29M | 117.06M | 107.99M | 111.47M | 97.89M | 95.97M | 101.23M | 104.4M | 78.11M | 89.9M | 96.68M | 105.77M | 81.67M | 96.79M | 111.66M |
Research & Development | 77.95M | 78.27M | 100.73M | 66.61M | 76.23M | 59.68M | 66.74M | 156.96M | 58.77M | 69.14M | 75.74M | 81.34M | 75.65M | 128.85M | 67.08M | 58.56M | 56.94M | 56.97M |
Other Expenses | n/a | n/a | -146.51M | n/a | 386K | 286K | n/a | 1.51M | -1.24M | n/a | 1.54M | n/a | -497K | 340K | 1.62M | 383K | 178K | 145K |
Operating Expenses | 211.46M | 204.63M | 84.3M | 199.9M | 193.3M | 167.67M | 178.21M | 254.85M | 154.74M | 170.38M | 180.14M | 159.44M | 165.55M | 225.53M | 172.85M | 140.23M | 153.72M | 168.63M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 9.4M | n/a | n/a | n/a | 5.5M | n/a | n/a | n/a | 8.98M | n/a | n/a | n/a |
Cost & Expenses | 232.19M | 225.03M | 106.1M | 218.76M | 211.53M | 190.62M | 196.1M | 269.48M | 162.2M | 172.05M | 182.55M | 161.58M | 168.21M | 228.48M | 175.41M | 146.91M | 158.93M | 173.33M |
Income Tax Expense | 13.54M | 8.79M | 17.34M | 6.04M | 3.79M | 4.45M | -6.09M | 13.03M | 5.23M | -1.92M | 835K | 768K | 443K | 485K | 189K | -332K | 473K | 21K |
Shares Outstanding (Basic) | 167.83M | 166.81M | 166.53M | 165.97M | 165.55M | 164.8M | 164.81M | 164.23M | 163.46M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
Shares Outstanding (Diluted) | 168.68M | 167.67M | 166.36M | 166.18M | 166.17M | 166.62M | 166.51M | 164.23M | 165.05M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
EPS (Basic) | 0.16 | 0.11 | 0.87 | 0.20 | 0.20 | 0.10 | 0.28 | -0.4 | 0.01 | -0.27 | -0.26 | -0.17 | -0.21 | -0.7 | -0.27 | -0.09 | -0.27 | -0.42 |
EPS (Diluted) | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.4 | 0.01 | -0.27 | -0.26 | -0.17 | -0.21 | -0.7 | -0.27 | -0.09 | -0.27 | -0.42 |
EBITDA | 40.21M | 22.24M | 12.2M | 31.64M | 33.01M | 20.74M | 36.58M | -56.05M | 4.8M | -53.16M | -45.57M | -30.36M | -33.14M | -112.5M | -44.12M | -14.32M | -42.78M | -65.88M |
EBIT | 40.21M | 19.29M | 6.99M | 31.64M | 37.18M | 21M | 39.7M | -57.78M | 6.34M | -53.58M | -46.06M | -30.87M | -33.65M | -113.02M | -44.66M | -15.3M | -43.71M | -66.77M |
Depreciation & Amortization | n/a | 2.95M | 5.21M | n/a | 2.57M | 5.53M | 1.64M | 1.76M | 1.77M | 426K | 489K | 506K | 515K | 516K | 535K | 985K | 929K | 895K |